Skip to product information
1 of 1

Shulph Ink

Handbook of Deep Learning in Biomedical Engineering and Health Informatics

Handbook of Deep Learning in Biomedical Engineering and Health Informatics

💎 Earn 395 Points (£3.95) on this item.

Important: Dispatches within 2 to 4 weeks
Regular price £79.00 GBP
Regular price £82.99 GBP Sale price £79.00 GBP
Sale Sold out
Taxes included. Shipping calculated at checkout.

YOU SAVE £3.99

  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension

Bulk ordering. Want 15 or more copies? Get a personalised quote and bigger discounts. Learn more about bulk orders.

  • More about Handbook of Deep Learning in Biomedical Engineering and Health Informatics


Recent technological advancements in biomedical deep learning have enabled the development of more accurate and efficient systems for medical image analysis, diagnosis, and treatment. These advancements include techniques such as convolutional neural networks, recurrent neural networks, and transfer learning, as well as platforms such as TensorFlow and PyTorch. Case studies have shown that these technologies can improve the accuracy of cancer detection, heart disease diagnosis, and drug discovery.

Format: Paperback / softback
Length: 318 pages
Publication date: 25 September 2023
Publisher: Apple Academic Press Inc.


The field of biomedical deep learning has seen significant recent advancements, revolutionizing the way we approach healthcare and disease diagnosis. These advancements have been driven by the increasing availability of large datasets, advanced computing power, and innovative techniques such as convolutional neural networks (CNNs) and recurrent neural networks (RNNs).

Biomedical deep learning systems are designed to analyze and interpret medical images, such as X-rays, CT scans, and MRI scans, to identify patterns and abnormalities that can be used to diagnose diseases. These systems use a combination of techniques, including image processing, feature extraction, and machine learning algorithms, to extract meaningful information from medical images.

One of the key techniques used in biomedical deep learning is convolutional neural networks (CNNs). CNNs are a type of neural network that is particularly well-suited for image processing tasks. They are designed to extract features from images in a hierarchical manner, starting from low-level features such as edges and textures and moving up to higher-level features such as shapes and objects. This allows the system to identify complex patterns and abnormalities that may be difficult to detect using traditional image analysis methods.

Recurrent neural networks (RNNs) are another important technique used in biomedical deep learning. RNNs are designed to process sequences of data, such as speech or text, and can remember information over long periods of time. This makes them well-suited for tasks such as speech recognition and natural language processing, which involve analyzing large amounts of data and making predictions based on patterns.

In addition to these techniques, biomedical deep learning systems also use a variety of platforms and tools to facilitate their development and deployment. These include popular machine learning frameworks such as TensorFlow and PyTorch, as well as cloud computing platforms such as Amazon Web Services and Microsoft Azure. These platforms provide access to powerful computing resources and allow researchers to scale their models and deploy them on a large scale.

One of the key applications of biomedical deep learning is in the field of cancer diagnosis. By analyzing medical images such as CT scans and MRI scans, these systems can identify patterns and abnormalities that are associated with different types of cancer. This allows doctors to make more accurate diagnoses and develop more effective treatment plans for patients.

Another area where biomedical deep learning is making significant strides is in the field of drug discovery. By analyzing large datasets of drug compounds and their interactions with biological molecules, these systems can identify potential new drug candidates and predict their efficacy and safety. This can help reduce the time and cost of drug development and improve the success rate of new treatments.

Despite the many benefits of biomedical deep learning, there are also challenges that need to be addressed. One of the biggest challenges is the lack of standardized datasets and evaluation metrics for evaluating the performance of these systems. This can make it difficult to compare the results of different studies and identify the most effective approaches.

Another challenge is the ethical implications of using large amounts of medical data for training these systems. There are concerns about privacy and confidentiality, as well as the potential for bias and discrimination in the results.

To address these challenges, researchers are working to develop new methods for evaluating the performance of biomedical deep learning systems and to ensure that they are transparent and ethical. They are also working to develop standardized datasets and evaluation metrics that can be used across different research communities.

In conclusion, the field of biomedical deep learning has seen significant recent advancements, revolutionizing the way we approach healthcare and disease diagnosis. These advancements have been driven by the increasing availability of large datasets, advanced computing power, and innovative techniques such as convolutional neural networks (CNNs) and recurrent neural networks (RNNs). Biomedical deep learning systems are designed to analyze and interpret medical images, such as X-rays, CT scans, and MRI scans, to identify patterns and abnormalities that can be used to diagnose diseases. These systems use a combination of techniques, including image processing, feature extraction, and machine learning algorithms, to extract meaningful information from medical images.

One of the key techniques used in biomedical deep learning is convolutional neural networks (CNNs). CNNs are a type of neural network that is particularly well-suited for image processing tasks. They are designed to extract features from images in a hierarchical manner, starting from low-level features such as edges and textures and moving up to higher-level features such as shapes and objects. This allows the system to identify complex patterns and abnormalities that may be difficult to detect using traditional image analysis methods.

Recurrent neural networks (RNNs) are another important technique used in biomedical deep learning. RNNs are designed to process sequences of data, such as speech or text, and can remember information over long periods of time. This makes them well-suited for tasks such as speech recognition and natural language processing, which involve analyzing large amounts of data and making predictions based on patterns.

In addition to these techniques, biomedical deep learning systems also use a variety of platforms and tools to facilitate their development and deployment. These include popular machine learning frameworks.

One of the key applications of biomedical deep learning is in the field of cancer diagnosis. By analyzing medical images such as CT scans and MRI scans, these systems can identify patterns and abnormalities that are associated with different types of cancer. This allows doctors to make more accurate diagnoses and develop more effective treatment plans for patients.

Another area where biomedical deep learning is making significant strides is in the field of drug discovery. By analyzing large datasets of drug compounds and their interactions with biological molecules, these systems can identify potential new drug candidates and predict their efficacy and safety. This can help reduce the time and cost of drug development and improve the success rate of new treatments.

Despite the many benefits of biomedical deep learning, there are also challenges that need to be addressed. One of the biggest challenges is the lack of standardized datasets and evaluation metrics for evaluating the performance of these systems. This can make it difficult to compare the results of different studies and identify the most effective approaches.

Another challenge is the ethical implications of using large amounts of medical data for training these systems. There are concerns about privacy and confidentiality, as well as the potential for bias and discrimination in the results.

To address these challenges, researchers are working to develop new methods for evaluating the performance of biomedical deep learning systems and to ensure that they are transparent and ethical. They are also working to develop standardized datasets and evaluation metrics that can be used across different research communities.

In conclusion, the field of biomedical deep learning has seen significant recent advancements, revolutionizing the way.

Weight: 635g
Dimension: 234 x 156 (mm)
ISBN-13: 9781774638170

This item can be found in:

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details